The latest biotech news

News and Trends 29 May 2015

Hyglos has a Solution Against Resistant Hospital Germs

Germany-based Hyglos and scientists from the universities of Tübingen, Münster and Munich join forces to develop a phage-based active substance against the dreaded hospital pathogen Staphylococcus aureus. Their secret lies in a highly effective protein from bacteria-specific viruses, the so-called bacteriophages, capable of rapidly killing the bacteria, which frequently occur in the nose. Due to the specific action of this […]

May 29, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 29 May 2015

Pfizer to Control Cellectis in a €1.5 Billion Deal?

Rumors are saying that French Cellectis is in talks about its potential sale. US-giant Pfizer is considered to be among the buyers. According to The Financial Time, two people familiar with the situation said Cellectis was in negotiations over a deal, but warned no outcome was certain. The Financial Time also declared that “one person […]

May 29, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 29 May 2015

Poxel is Looking towards Japan’s Lucrative Diabetes Market

Poxel, the French company that made a €27M IPO last February, announced the successful conclusion of a phase 1 clinical trial in Japanese subjects with Imeglimin, its lead drug candidate. Imeglimin has already completed phase 2 clinical trials in type 2 diabetes patients in the US and EU and is ready for Phase III. This […]

May 29, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 28 May 2015

Biotechs outperformed in the top 40 European Tech Companies

EnterNext, the Euronext subsidiary dedicated to promoting and growing the market for SMEs (Small and Medium-size companies), announced the launch of Tech 40, a label recognizing innovative European SMEs. Tech 40 puts young tech companies listed on Euronext markets – in Amsterdam, Brussels, Lisbon or Paris – under the spotlight. Companies awarded with the Tech 40 are operating in […]

May 28, 2015 - 2 minutesmins - By Nicolas Sainte-Foie

News and Trends 28 May 2015

Deinove Reaches Critical Milestones and Gets Recognition in the US

May 2015 is a great month for Deinove! The French company focused on Deinococci bacteria for green chemistry. Deinove reached critical milestone achievements in its industrial collaboration with Avril and their scientists gained major recognition in the US. Deinove is definitely on the front of the stage! A few days ago, Emmanuel Petiot, CEO of Deinove, declared that “All Deinove teams are […]

May 28, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 27 May 2015

Berlin’s biotech ecosystem, a fast-growing European hotspot

The Bionnale 2015, a major networking event for biotech in Berlin, is taking place today. Talks about Berlin’s cluster gave me a good insight on what’s happening here. Don’t expect Berlin to be a groundbreaking place like Boston or San Diego. The German capital has more conventional assets, but they’re definitely building a solid ecosystem. With more […]

May 27, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 27 May 2015

Qiagen offers a powerful bioinformatics tool for Next-gen sequencing

Qiagen has launched its Qiagen Clinical Insight bioinformatics content and software platform. The software aims at clinical testing labs that perform next generation sequencing. The platform allows interpreting and reporting on genomic variants identified in the sequencing assays. The Clinical Insight platform is a potent tool that evaluates genomic variants comparing them with published biomedical […]

May 27, 2015 - 1 minutemin - By Lourdes Riquelme

News and Trends 27 May 2015

NewCo, the union of Sorin and Cyberonics

[UPDATE 27/05/2015]: Sorin’ shareholders approved the merger with Cyberonics in an Extraordinary Meeting. Sorin and Cyberonics, agreed on a merger plan to create a new global leader in medical technologies with a combined equity value of approximately €2.4Bn based on the closing price of Sorin and Cyberonics shares of 25th February. Sorin and Cyberonics will combine […]

May 27, 2015 - 3 minutesmins - By Lourdes Riquelme

News and Trends 27 May 2015

Amgen dumps suicidal-related AstraZeneca’s psoriasis project

AstraZeneca might be facing a public crisis after its partner, Amgen, decided to abandon their common project on psoriasis. The Americans made a getaway from the collaboration after patients treated with brodalumab not only reported to have suicidal ideation, but even committed suicide… AstraZeneca and Amgen’s partnership started back in 2012, as both companies resolved to jointly […]

May 27, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 26 May 2015

CRISPR-armed Viruses to kill Antibiotic-Resistant Bacteria

Antibiotics abuse is creating a whole new generation of antibiotic-resistant bacteria. As the tolerance to antibiotics grows, the battle against bacteria is getting harder and becoming a public issue. However, Humans are not the only ones trying to fight bacteria. Some viruses, the phages, have been doing it for millenniums. Udi Qimron and his team […]

May 26, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 26 May 2015

L’Oreal is Bioprinting Human Skin to Stop Animal Testing

A huge improvement could shake the cosmetic testing field very soon. L’Oreal, the French world leader in beauty cosmetics, mostly known for its make-up and hair care products, has just started a partnership with Organovo to print human skin. The amazing thing here is that L’Oreal has already been thinking about giving priority to human skin tests […]

May 26, 2015 - 3 minutesmins - By Julie Lellouche

News and Trends 25 May 2015

Invectys focuses on Telomers to develop a Universal Cancer Vaccine

French startup Invectys believes to have found the solution to cancer: one vaccine to cure them all! By targeting telomerase, this new immunotherapy could theoretically fight 95 % of all human cancers. When a cell divides, a small piece of DNA, called telomere, is lost at both ends of each chromosome. Telomerase adds these pieces of DNA again at the end of […]

May 25, 2015 - 3 minutesmins - By Joachim Eeckhout

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Hyglos has a Solution Against Resistant Hospital Germs

Pfizer to Control Cellectis in a €1.5 Billion Deal?

Poxel is Looking towards Japan’s Lucrative Diabetes Market

Biotechs outperformed in the top 40 European Tech Companies

Deinove Reaches Critical Milestones and Gets Recognition in the US

Berlin’s biotech ecosystem, a fast-growing European hotspot

Qiagen offers a powerful bioinformatics tool for Next-gen sequencing

NewCo, the union of Sorin and Cyberonics

Amgen dumps suicidal-related AstraZeneca’s psoriasis project

CRISPR-armed Viruses to kill Antibiotic-Resistant Bacteria

L’Oreal is Bioprinting Human Skin to Stop Animal Testing

Invectys focuses on Telomers to develop a Universal Cancer Vaccine

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!